Fig. 1: Trial profile.

Response was evaluated per RECIST version 1.1. HCC, hepatocellular carcinoma; IMRT, intensity modulated radiotherapy; PR, partial response; SD, stable disease; PD, progressive disease; pCR, pathological complete response; MPR, major pathological response.